Table 2 Percentage of proliferating CD4+ T cells co-cultivated with imDCs or mDCs
From: Functional characterization of biodegradable nanoparticles as antigen delivery system
Treatment | Antigen presenting cells | |
|---|---|---|
imDCs | mDCs | |
Null | 1.7 % | 0.1 % |
OVA | 17.4 % | 32.0 % |
OVA 5X | 12.8 % | 27.0 % |
OVA 500X | 22.4 % | 28.9 % |
OVA-PLGA | 31.9 % | 35.3 % |
OVA-PLGA 5X | 24.8 % | 34.4 % |
OVA-PLGA/PEI | 17.1 % | 16.0 % |
OVA-PLGA/PEI 5X | 5.0 % | 15.9 % |
PHA | 26.2 % | 27.4 % |